Information Provided By: 
Fly News Breaks for October 19, 2015
ATHN
Oct 19, 2015 | 07:42 EDT
Canaccord said they are cautious on athenahealth heading into Q3 results, as they believes Street estimates for Doc additions may be too high. The company is due to report on Thursday and previously had given guidance that they expect to be at or above the mid-point of guidance for 2015. Canaccord maintained its Buy rating and $125 price target on athenahealth shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN
